Qida Hu

13PUBLICATIONS
26CO-AUTHORS
Molecular targetsMedical devicesNanometrologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 19, 2026
Antigen Spreading via Localized Administration Enhances Adoptive TCR-T Cell Therapy in Pancreatic Cancer.

|Jan 15, 2025
Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice.

Yuxuan Chen, Xiaohong Chen, Yao Zhang

|Jan 03, 2025
Correction: Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.

Meng Wang, Qida Hu, Junmin Huang

|Mar 29, 2023
A tumor microenvironment-stimuli responsive nano-prodrug for overcoming gemcitabine chemoresistance by co-delivered miRNA-21 modulator.

Fu Zhang, Zhuo Yao, Piaopiao Jin

|Mar 27, 2023
In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma.

Meng Wang, Qida Hu, Junming Huang

|Jan 26, 2023
An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer.

Junming Huang, Meng Wang, Fu Zhang

Pageof 3

Frequent Collaborators

3 joint publications

Yuan Ping

2 joint publications

Haifeng Huang

2 joint publications

Piaopiao Jin

2 joint publications

Hanjin Yang